AlzoSure® Predict, a simple minimally‐invasive blood test to predict the early onset of Alzheimer’s disease before the manifestation of clinical symptoms

Background Ongoing research seeks to identify blood‐based biomarkers able to predict the onset and progression of Alzheimer’s disease (AD). AlzoSure® Predict is a rapid, minimally‐invasive blood test that predicts the early onset of AD up to, at least, 6 years in advance of clinical symptoms. Method...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Alzheimer's & dementia 2022-12, Vol.18 (S6), p.n/a
Hauptverfasser:	Piccirella, Simona, Van Neste, Leander, Fowler, Christopher, Masters, Colin L, Fripp, Jurgen, Doecke, James D, Xiong, Chengjie, Uberti, Daniela, Kinnon, Paul
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!